S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Oxford Bank Reports Steady Growth in Second Quarter 2026

Oxford Bank Corporation posted a consolidated net income of $2.71 million for the second quarter of 2026, marking a significant recovery from the $1.53 million reported in the first three months of the year, though figures remain slightly below the $2.78 million recorded during the same period in 2025.

Oxford Bank Reports Steady Growth in Second Quarter 2026
Photo: Bio & News

Chairman and CEO David Lamb attributed the rebound to normalized business growth and a disciplined approach to lending. The company saw its loan portfolio expand by $21 million, while deposits rose by $29 million, bolstered by the bank's municipal banking platform and commercial finance division. Oxford Commercial Finance leases reached a record $147 million by the end of June, signaling sustained demand for the bank’s specialized financing products.

Financial performance was further supported by a widening net interest margin, which reached 4.97% as asset yields climbed to 7.15%. While the bank faces costs associated with managing legacy nonperforming assets, management emphasized that these investments are targeted at long-term risk reduction. Total assets grew to $930.5 million, and shareholders' equity increased to $113.5 million, reflecting a book value per share of $45.58. Looking ahead, the bank intends to leverage its strong capital position to pursue strategic funding channels as it balances growth with credit quality standards.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!